November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO
May 2, 2024, 14:30

Glecirasib demonstrates efficacy in KRASG12C-mutated NSCLC – ASCO

American Society of Clinical Oncology (ASCO) shared on X:

Breaking news from the ASCO Plenary Series:

Glecirasib demonstrates encouraging efficacy and safety in KRASG12C-mutated Non- Small Cell Lung Cancer (NSCLC) in phase 2 trial from China.

ASCO Daily News has more.”

Glecirasib

Source: ASCO/X